Canada vs Chad: Access to anti-retroviral drugs, female
Canada
72.0%
in 2022
Chad
72.0%
in 2024
Canada rank
76th
Chad rank
76th
Access to anti-retroviral drugs, female over time
- Canada
- Chad
How they compare
Canada currently reports 72.0% against 72.0% in Chad, a difference of 0.0%.
Across all 23 years both countries report, Canada has been ahead every year.
Canada ranks 76th and Chad ranks 76th of 141 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Canada | Chad | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.2% | 5.0% | 21.2% | Canada |
| 2010s | 62.6% | 37.4% | 25.2% | Canada |
| 2020s | 73.7% | 58.7% | 15.0% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Canada or Chad?
- Canada, at 72.0% against 72.0% in Chad as of 2022.
- What is the difference in access to anti-retroviral drugs, female between Canada and Chad?
- 0.0%, with Canada ahead.
- How many years of comparable data are there for Canada and Chad?
- 23 years are reported by both, from 2000 to 2022.
- How do Canada and Chad rank globally for access to anti-retroviral drugs, female?
- Canada ranks 76th and Chad ranks 76th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.